Therefore, our data raises the question of whether eQTLs activated following an infectious disease could contribute to risk of post-infection sequelae such as recurrent TB, akin to reported hypermethylation in the promoter region of interferon induced protein 44 Like (IFI44L) gene post-COVID-19 [68]. This evidence concerns the gene IFI44L and COVID-19.